Therapeutic Group

Indication Dosage

Antihemophilic Factor, also known as Factor VIII, is a medication used to treat a bleeding disorder called hemophilia A. People with hemophilia A have a deficiency of this important clotting factor in their blood, which can lead to excessive bleeding and difficulty in stopping bleeding after injuries or surgeries. Antihemophilic Factor is given to replace the missing or low Factor VIII in the blood, helping to prevent or control bleeding episodes in individuals with hemophilia A. It's an essential treatment that allows people with hemophilia A to lead more normal and active lives by reducing the risk of severe bleeding.

Classical Haemophilia (hemophilia A) With Deficiency Of Plasma Clotting Factor (factor Viii), To Provide Temporarily Replacing The Clotting Factor To Prevent Bleeding Episodes And To Perform Surgery On Haemophiliacs: See Literature For Dosage.

Content

Pregnancy

Positive Evidence Of Risk; Use Only When No Safer Alternative Exists For A Serious Problem.

Stability

Contra Indications

Precautions

Lactation

Side Effects